home / stock / xene / xene quote
Last: | $40.10 |
---|---|
Change Percent: | 0.43% |
Open: | $39.33 |
Close: | $40.10 |
High: | $40.82 |
Low: | $38.85 |
Volume: | 255,970 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$40.1 | $39.33 | $40.1 | $40.82 | $38.85 | 255,970 | 04-25-2024 |
$39.5 | $41.16 | $39.5 | $41.16 | $39.24 | 325,554 | 04-24-2024 |
$41.09 | $40.23 | $41.09 | $41.59 | $39.52 | 320,120 | 04-23-2024 |
$40.01 | $39.92 | $40.01 | $40.31 | $39.18 | 395,140 | 04-22-2024 |
$39.88 | $40.48 | $39.88 | $41.26 | $39.01 | 362,875 | 04-19-2024 |
$40.31 | $41.72 | $40.31 | $41.72 | $39.59 | 324,121 | 04-18-2024 |
$41.63 | $41.49 | $41.63 | $41.99 | $41.18 | 393,800 | 04-17-2024 |
$41.49 | $41.31 | $41.49 | $42.025 | $41 | 409,168 | 04-16-2024 |
$41.31 | $41.33 | $41.31 | $41.71 | $40.62 | 362,008 | 04-15-2024 |
$41.3 | $42.67 | $41.3 | $42.67 | $40.54 | 582,422 | 04-12-2024 |
$42.97 | $42.36 | $42.97 | $43.09 | $42.14 | 188,192 | 04-11-2024 |
$42.43 | $42.58 | $42.43 | $43.3 | $41.99 | 209,161 | 04-10-2024 |
$43.03 | $42.58 | $43.03 | $43.085 | $42.465 | 203,498 | 04-09-2024 |
$42.62 | $42.25 | $42.62 | $42.79 | $41.75 | 265,329 | 04-08-2024 |
$42.25 | $42.04 | $42.25 | $42.775 | $41.48 | 183,991 | 04-05-2024 |
$42.21 | $41.5 | $42.21 | $42.68 | $41.3615 | 459,334 | 04-04-2024 |
$41.3 | $41.47 | $41.3 | $41.75 | $40.97 | 276,669 | 04-03-2024 |
$41.47 | $41.85 | $41.47 | $42.01 | $41.135 | 237,071 | 04-02-2024 |
$42.14 | $43.18 | $42.14 | $43.18 | $41.26 | 240,125 | 04-01-2024 |
$43.05 | $42.88 | $43.05 | $43.545 | $42.375 | 364,266 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Xenon Pharmaceuticals Inc. Company Name:
XENE Stock Symbol:
NASDAQ Market:
Xenon Pharmaceuticals Inc. Website:
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutic...
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy of Neurology (AAN) 2024 Annual Meeting in Denver,...
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neurology-focused biopharmaceutical ...